CINF
58
3
PEG
36
2
TXT
70
-2
COST
53
2
SIG
67
-5
MS
61
2
AIG
44
-13
EXR
44
4
BWA
55
-5
FRT
45
2
PLD
58
2
L
67
3
BSX
42
2
QRVO
59
6
NDAQ
57
2
COF
47
-3
PNR
30
-2
TSN
58
2
PSA
35
15
NRG
45
3
CINF
58
3
PEG
36
2
TXT
70
-2
COST
53
2
SIG
67
-5
MS
61
2
AIG
44
-13
EXR
44
4
BWA
55
-5
FRT
45
2
PLD
58
2
L
67
3
BSX
42
2
QRVO
59
6
NDAQ
57
2
COF
47
-3
PNR
30
-2
TSN
58
2
PSA
35
15
NRG
45
3
Financhill
Back

Unicycive Therapeutics, Inc. 10K Form

Sell
42

UNCY
Unicycive Therapeutics, Inc.

Last Price:
$6.95
Seasonality Move:
-24.79%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive UNCY News And Ratings

See the #1 stock for the next 7 days that we like better than UNCY

UNCY Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-6M
Price / Cash Flow: 0
Annual Sales: $1.80
Price / Book: 5.79

Profitability

EPS (TTM): -2.79780
Net Income (TTM): $-33.5M
Gross Margin: $-572K
Return on Equity: -166.6%
Return on Assets: -93.61%

Unicycive Therapeutics, Inc. Earnings Forecast

Key Unicycive Therapeutics, Inc. Financial Ratios

  • Per Share Earnings over the last 8 years have been positive in 1 years.

Unicycive Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: UNCY
Website: unicycive.com

Debt

Debt-to-Equity Ratio: 0.01
Current Ratio: 3.83
Quick Ratio: 3.25

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0.75

UNCY Technical Analysis vs Fundamental Analysis

Sell
42
Unicycive Therapeutics, Inc. (UNCY) is a Sell

Is Unicycive Therapeutics, Inc. a Buy or a Sell?